Latest filing published 15 Aug 2013 for Axogen, Inc., €151k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -23.0%Entry US$3.00 · Close at T+365 US$2.31
- -39.6%Entry US$4.82 · Close at T+365 US$2.91
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John Frederick Harper: trading record in brief
John Frederick Harper is a declared insider of Axogen, Inc., with filings sourced from SEC (Form 4). The record holds 3 filings, for trades running from 10 October 2011 to 14 August 2013.
No open-market sale appears; the market trades are 2 purchases worth €393k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant. So far in 2013, the count stands at 2 purchases and no sales.
Most recently, on 15 August 2013, the filings show an open-market purchase worth €151k in Axogen, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John Frederick Harper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 66,666 shares@ US$3.00Common StockSEC:0001209191-13-040866:0Canonical exit: 12 Nov 2013 (T+90)
- 86,557 shares@ US$3.61Common StockSEC:0001209191-13-021074:0Canonical exit: 30 Dec 2012 (T+90)
2 of 2 declarations
